Synapse - Oncology Research and Treatment

Oncology Research and Treatment

Published by: S. Karger AG

People

Groups

Department of Medicine (2)
Melanoma and Immunotherapeutics Service (2)
Solid Tumor Oncology Division (2)
GSK Faculty (1)
Thoracic Oncology (1)

Search Within

Results (2)

Evaluation of nivolumab (nivo) alone and in combination with ipilimumab (ipi) in patients (pts) with advanced (adv) small-cell lung cancer (SCLC): First report of a randomized expansion cohort from the CheckMate 032 trial

Meeting Abstract

Atmaca, A.; Hellmann, M. D.; Ott, P. A.; Zugazagoitia, J.; Ready, N.; Hann, C. L.; De Braud, F.; Antonia, S.; Ascierto, P.; Moreno, V.; more...
Oncology Research and Treatment (2017)

Fulltext@MSK | Save

Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients with advanced melanoma (MEL) (CheckMate 067)

Meeting Abstract

Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M. S.; more...
Oncology Research and Treatment (2016)

Fulltext@MSK | Save

Oncology Research and Treatment – authorized name for:

Name	ISSN / ISBN	Publisher
Oncology Research and Treatment	22965270	Unknown
Oncology Research and Treatment	2296-5270	Karger
Oncology research and treatment	22965262	Unknown
Oncology Research and Treatment	2296-5270	S. Karger AG
Oncology Research and Treatment	2296-5270	S. Karger AG